Amanta Healthcare Shares List at 7% Premium on NSE and BSE
The Initial Public Offering (IPO) of Amanta Healthcare was open for subscription from September 1 to September 3, 2025, and was oversubscribed by 82.61 times,
Amanta Healthcare Limited made a strong debut on the Indian stock exchanges today, with its shares listing at a premium over the issue price. The stock opened at ₹135 on the National Stock Exchange (NSE), marking a 7.14% gain from the issue price of ₹126 per share. On the Bombay Stock Exchange (BSE), shares debuted at ₹134.90, reflecting a 6.35% premium.
The listing aligns with market expectations, as indicated by the grey market premium (GMP) of ₹9 per share prior to the debut, suggesting a listing price of around ₹135.
IPO Subscription and Allotment Details
The Initial Public Offering (IPO) of Amanta Healthcare was open for subscription from September 1 to September 3, 2025, and was oversubscribed by 82.61 times, according to data from the National Stock Exchange. The retail category was subscribed 54.98 times, while the Non-Institutional Investors (NIIs) segment saw a subscription of 209.42 times. Qualified Institutional Buyers (QIBs) subscribed 35.86 times, indicating strong investor interest across all categories.
The IPO comprised a fresh issue of 1 crore equity shares, raising ₹126 crore for the company. The allotment was finalized on September 4, with shares credited to demat accounts on September 9, coinciding with the listing date.
Use of IPO Proceeds
Amanta Healthcare plans to utilize the proceeds from the IPO to fund capital expenditure for expanding its manufacturing capabilities. Approximately ₹70 crore will be allocated to set up a new SteriPort manufacturing line at the company's Hariyala, Kheda facility in Gujarat, expected to commence operations by January 2026. An additional ₹30.13 crore will be used to develop a new Small Volume Parenteral (SVP) manufacturing line at the same facility, targeted for completion by January 2027. The remaining funds will support general corporate purposes.
Company Overview
Established in December 1994, Amanta Healthcare is a leading pharmaceutical company specializing in sterile liquid products. The company's product portfolio includes intravenous fluids, ophthalmic solutions, respiratory care products, and irrigation solutions. Amanta Healthcare employs advanced technologies such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) in its manufacturing processes, ensuring high-quality standards in its offerings.